158 results
Page 4 of 8
8-K
wqglawd1
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
8-K
EX-1.1
b1juc9dy60bod5crk
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
424B5
k3dza95as7hr0vzt
27 Apr 22
Prospectus supplement for primary offering
6:30am
8-K
EX-3.2
abx0gf
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-3.1
mb01 ieh9deilmv
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.1
29r4fs4z
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.2
g9t989
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-10.1
qpdlt98iw3sbaytyg
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.3
84ynsbs ctp
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
424B5
03l1bmqb9 ppxkkngy
14 Mar 22
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
g4c vqnxqmf2g
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-1.1
tfsa7z bin
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
qov3 8vt6
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
424B5
9bcois9i 30
10 Jan 22
Prospectus supplement for primary offering
8:00am